The Patent Finder

Ironshore Pharmaceuticals & Development, Inc.

Also on record
Records under this name other than the patents Ironshore Pharmaceuticals & Development, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.

Showing 1 to 6 of 6 · Back to Ironshore Pharmaceuticals & Development, Inc.

PatentTitleStatus Expires Confidence
US 10,617,651Compositions for Treatment of Attention Deficit Hyperactivity Disorder
In force
 · Medium confidence
In forceMedium confidence
17/315,133Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Abandoned
Abandoned Jan 31, 2023
AbandonedAbandoned Jan 31, 2023
17/316,252Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Abandoned
Abandoned Sep 15, 2026
AbandonedAbandoned Sep 15, 2026
17/557,476Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Abandoned
Abandoned Apr 5, 2024
AbandonedAbandoned Apr 5, 2024
18/057,819Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
19/267,000Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited